TCTMD

Your source for breaking news, topical videos, and slides covering cardiovascular disease and interv
(11)

TCTMD is the most comprehensive on-line resource in interventional cardiology and provides indepth coverage of the percutaneous treatment of cardiovascular disease. Since its launch at TCT 2000, TCTMD has provided clinicians and industry professionals myriad ways to keep up-to-date in the ever-evolving field, including news and data from conferences hosted around the world as well as information about the latest devices and drugs used in the daily practice of cardiovascular medicine.

09/04/2024

The recommendations, based on STEP, CRHCP, and ESPRIT data, are now more in line with US guidance.

09/04/2024

An early CV benefit was apparent, although there’s still some question about the longer-term impact versus culprit-only PCI.

09/04/2024

The trial drew praise for its dedicated look at female patients, but it’s unclear how the data pertain to other valves.

09/04/2024

Critics were quick to point out that this small, short-term trial—mostly in patients with preserved EF—had no medical arm.

09/04/2024

There was no reduction in CV death, but HF doctors are happy to gain another agent for use in HFmrEF/HFpEF patients.

09/04/2024

Quickly cutting non-HDL cholesterol after MI lowers the risk of MACE compared with stepwise use of lipid-lowering therapy.

09/04/2024

The results reinforce existing guidelines that advise pulling back on antithrombotic therapy in the chronic phase.

09/04/2024

There was a reduction in MACE with PCI before TAVI, but that doesn’t mean revascularization should be the norm, say experts.

09/03/2024

Notable in the trial was the use of OCT for stent optimization, which investigators say should be a key takeaway.

09/03/2024

POPular PAUSE TAVI bolsters what one expert says has become standard of care at most centers: interrupting treatment

09/03/2024

High-sensitivity CRP, LDL, and Lp(a) each have an impact, Paul Ridker says, calling for universal screening early in life.

09/03/2024

This month’s greatest hits ran the gamut: a price drop for tirzepatide, TriClip’s US debut, advances in HF, and more.

09/03/2024

Researchers say that the current 2a recommendation to use no-touch harvesting should be downgraded in light of new evidence.

09/03/2024

As in the TRILUMINATE Pivotal trial, those benefits weren’t accompanied by significant reductions in harder outcomes.

09/03/2024

Results from BedMed and BedMed-Frail, as well as a meta-analysis, are consistent with what was seen in the TIME trial.

09/03/2024

Combining low doses of effective drugs and helping patients cut back on their total number of pills are among the advantages.

09/03/2024

(UPDATED) A flurry of papers, including a meta-analysis of the three RCTs, reflect big interest and even larger, unanswered questions.

09/02/2024

wraps up today! Check out the coverage from the whole weekend here: https://bit.ly/47cAoaw

09/02/2024

No impact was seen on mortality between the invasive and medical arms, but other endpoints may mean more to patients.

09/02/2024

Discussion at ESC 2024 centered on questions of dosing, patients, and appropriate targets for this novel antithrombotic.

09/02/2024

(UPDATED) Neither continuation nor discontinuation had an advantage, opening the door for personalized decisions.

09/02/2024

(UPDATED) The study failed to show that stopping beta-blockers after MI was noninferior to continuing treatment, surprising researchers.

09/02/2024

Though there are limitations, the sham-controlled trial shows “no clinically relevant placebo effect,” a researcher says.

09/02/2024

(UPDATED) The results set vutrisiran up as a first-line agent or as an add-on to stabilizer therapy in patients who are progressing.

09/01/2024

New French data are reassuring but emphasize the need for follow-up care in more severe cases, authors say.

Address

1700 Broadway
New York, NY
10019

Website

http://www.tctmd.com/

Alerts

Be the first to know and let us send you an email when TCTMD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Videos

Interested in how interventional cardiologists use the JenaValve Trilogy Valve to treat aortic regurgitation? Hear from two experts, Matti Adams and Sam Dawkins, as they discuss the benefits of this novel treatment. #sponsored https://www.tctmd.com/videos/real-world-experience-of-a-dedicated-tavi-for-ar-with-the-jenavalve-trilogy-valve.6355242267112

Vinod Thourani and Philippe Généreux speak with Shelley Wood about the possibilites and limitations of TAVI procedures. https://www.tctmd.com/videos/on-record-new-terrain-for-tavi.6353829708112

Shelley Wood speaks with Philippe Pibarot and Michael Reardon about what they are anticipating in valve and trial design future outcomes. https://www.tctmd.com/videos/valve-durability-what-to-watch-for.6353883938112

Javier Escaned and Mamas Mamas discuss the use of a hierarchical strategy assessing physiology and vascular function at the time of angiography for CCS patients in the AID-ANGIO trial. https://www.tctmd.com/videos/beyond-the-data-the-aidangio-trial.6353460775112

Ling Tao and Bernardo Cortese join Mamas Mamas at #EuroPCR2024 to discuss REC-CAGEFREE II trial, different DAPT durations, DCB angioplasty and more. https://www.tctmd.com/videos/beyond-the-data-best-dapt-for-dcbs.6353046934112

Mamas Mamas, Ole De Backer, and Hendrik Treede discuss the NOTION-2 trial and potential implications in choosing TAVI versus surgery with young, low-risk AS patients. https://www.tctmd.com/videos/beyond-the-data-lowrisk-patients-in-notion2.6353022193112

During #THT24, Harriette Van Spall and Wilfried Mullens sat down to review decongestive therapy options for heart failure patients. https://www.tctmd.com/videos/decongestion-therapies-in-heart-failure.6349247757112

Jung-Min Ah and Bruno Scheller join Mamas Mamas to discuss the use and future of DCBs for coronary artery disease. https://www.tctmd.com/videos/beyond-the-data-drug-coated-balloons-for-cad.6352611687112

What's new in heart failure clinical trials? Mariell Jessup and Harriette Van Spall share thoughts on emerging therapies and innovations in HF care from THT 2024 sessions. https://www.tctmd.com/videos/hf-clinical-trials-emerging-therapies-and-approaches-to-care.6349247477112

Jagmeet Singh and Harriette Van Spall discuss the implications of AI in cardiovascular care, including potential algorithmic bias and future capacities of AI in the realm of heart failure. #tht2024 https://www.tctmd.com/videos/ai-in-heart-failure.6348743623112

Only a few more days left to take our brief survey. Let us know what you want to see from TCTMD in the future! https://www.tctmd.com/Survey2024

TCTMD survey!

Shape the future of TCTMD by completing our survey and telling us what you want to see from a cardiology website. Now is your chance to be heard and share your input! Click here: https://www.tctmd.com/Survey2024

Shape the future of TCTMD.com! Take our five-minute survey now and help us deliver what you want from a cardiology website. Click here. https://www.tctmd.com/Survey2024

Shape the future of TCTMD.com! Take our five-minute survey now and help us deliver what you want from a cardiology website. Click here: https://www.tctmd.com/Survey2024

Love puzzles? Give our 2023 cardiology crossword challenge a shot for a chance to win great prizes! https://www.tctmd.com/2023-cardiology-crossword-challenge

Our Cardiology Crossword Challenge is back for 2023! Can you solve the clues for a chance at valuable prizes? https://www.tctmd.com/2023-cardiology-crossword-challenge

It's back! TCTMD's cardiology crossword challenge has returned for the 2023 holiday season. Can you crack the clues for a chance to win a prize? https://www.tctmd.com/2023-cardiology-crossword-challenge

Introducing Allia™ IGS Pulse

Introducing #Allia™ IGS Pulse. All the power of your Allia™ IGS assistant with a new image chain engineered to provide exceptional cardiac imaging at the right dose. Cardiac imaging excellence for a visible impact. #Sponsored #GEHealthCare #PatientFirst #Interventional #Cardiology #Innovation Allia™ IGS Pulse is not available for sale in all countries.

As cardiology meetings prioritize fresh faces and more diversity, professional society leaders tell TCTMD that some bullying persists beyond—and possibly in reaction to—their efforts to create change. https://www.tctmd.com/news/bullying-cardiology-has-more-diversity-led-backlash

Can you crack TCTMD’s 2022 Cardiology Crossword Challenge? Get all clues correct, submit your completed puzzles by 12/23, and you will be entered in a draw for one FREE registration for TCT 2023 or one of five platinum memberships for TCTMD. #CardioXword https://bit.ly/3intkCo